B9182 / Janssen-Cilag Pty Ltd / The New England Journal / /
Country
Italy / Australia / /
Currency
USD / /
Event
FDA Phase / /
IndustryTerm
cancer therapy / leukemia / treatment of a patient with metastatic advanced prostate cancer / treatment of metastatic advanced prostate cancer / therapy for patients with metastatic prostate cancer / /
MedicalCondition
cancers / leukemia / Proposed Therapy Prostate cancer / metastatic prostate cancer / common cancer / symptomatic hormone-resistant prostate cancer / cancer / disease / metastatic advanced prostate cancer / progressive disease / tumour / asymptomatic hormone-refractory carcinoma / metastatic castration-resistant prostate cancer / pain / refractory prostate cancer / symptomatic hormoneresistant prostate cancer / symptomatic hormonerefractory prostate cancer / prostate cancer / resistant prostate cancer / hormone-refractory prostate cancer / /